Nan Bai

1.1k total citations
54 papers, 812 citations indexed

About

Nan Bai is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Nan Bai has authored 54 papers receiving a total of 812 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 13 papers in Cardiology and Cardiovascular Medicine and 10 papers in Surgery. Recurrent topics in Nan Bai's work include Coronary Interventions and Diagnostics (6 papers), Antiplatelet Therapy and Cardiovascular Diseases (6 papers) and Atrial Fibrillation Management and Outcomes (5 papers). Nan Bai is often cited by papers focused on Coronary Interventions and Diagnostics (6 papers), Antiplatelet Therapy and Cardiovascular Diseases (6 papers) and Atrial Fibrillation Management and Outcomes (5 papers). Nan Bai collaborates with scholars based in China, United States and India. Nan Bai's co-authors include Rong Xiang, Xiaoyue Tan, Yunping Luo, Yuquan Wei, Min Xiong, Ze Liu, Luyuan Li, Chenghu Liu, Zhuhong Zhang and Yanhua Liu and has published in prestigious journals such as Nature Communications, Cancer Research and Life Sciences.

In The Last Decade

Nan Bai

50 papers receiving 790 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nan Bai China 15 296 143 98 93 92 54 812
Yanira Riffo‐Vasquez United Kingdom 19 298 1.0× 327 2.3× 118 1.2× 48 0.5× 58 0.6× 43 1.4k
Kazuhiko Matsuno Japan 16 306 1.0× 85 0.6× 69 0.7× 85 0.9× 70 0.8× 62 782
Claudia Castruita-De la Rosa Mexico 8 359 1.2× 160 1.1× 179 1.8× 78 0.8× 48 0.5× 12 1.2k
Felipe Massó Mexico 18 315 1.1× 203 1.4× 60 0.6× 105 1.1× 28 0.3× 77 935
Xuefeng Zhang China 17 323 1.1× 67 0.5× 86 0.9× 38 0.4× 26 0.3× 72 805
Shuang Wu China 16 322 1.1× 74 0.5× 73 0.7× 92 1.0× 17 0.2× 64 920
Minjoo Yoo South Korea 9 199 0.7× 210 1.5× 45 0.5× 119 1.3× 24 0.3× 14 793
Robert Suriano United States 17 473 1.6× 168 1.2× 189 1.9× 45 0.5× 92 1.0× 36 1.1k
Chuang Yuan China 16 301 1.0× 99 0.7× 47 0.5× 86 0.9× 19 0.2× 32 710

Countries citing papers authored by Nan Bai

Since Specialization
Citations

This map shows the geographic impact of Nan Bai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nan Bai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nan Bai more than expected).

Fields of papers citing papers by Nan Bai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nan Bai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nan Bai. The network helps show where Nan Bai may publish in the future.

Co-authorship network of co-authors of Nan Bai

This figure shows the co-authorship network connecting the top 25 collaborators of Nan Bai. A scholar is included among the top collaborators of Nan Bai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nan Bai. Nan Bai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liang, Beibei, et al.. (2025). Therapeutic drug monitoring of isavuconazole: Trends and update. International Journal of Antimicrobial Agents. 66(6). 107619–107619.
3.
Yang, Qingqing, et al.. (2024). Ethical Review Key Points of Brain-Computer Interface Clinical Research. 1–4. 1 indexed citations
4.
Niu, Ying, et al.. (2022). Efficacy of intravascular imaging-guided drug-eluting stent implantation: a systematic review and meta-analysis of randomized clinical trials. BMC Cardiovascular Disorders. 22(1). 327–327. 9 indexed citations
5.
Niu, Ying, et al.. (2022). Efficacy of Drug-Coated Balloon Approaches for de novo Coronary Artery Diseases: A Bayesian Network Meta-Analysis. Frontiers in Cardiovascular Medicine. 9. 899701–899701. 2 indexed citations
6.
Bai, Nan, et al.. (2021). Management of acute coronary syndrome in the context of coronavirus disease 2019. Medicine. 100(1). e24151–e24151. 2 indexed citations
8.
Liu, Guangzhong, Jiachen Lv, Fengxiang Yun, et al.. (2020). Sacubitril/valsartan attenuates atrial electrical and structural remodelling in a rabbit model of atrial fibrillation. European Journal of Pharmacology. 881. 173120–173120. 45 indexed citations
9.
Bai, Nan, Yanyan Wang, Yuanqi Wang, et al.. (2020). Tranilast prevents doxorubicin-induced myocardial hypertrophy and angiotensin II synthesis in rats. Life Sciences. 267. 118984–118984. 16 indexed citations
10.
Liu, Guangzhong, Jianqiang Li, Guangnan Li, et al.. (2019). Rotenone and 3-bromopyruvate toxicity impacts electrical and structural cardiac remodeling in rats. Toxicology Letters. 318. 57–64. 14 indexed citations
11.
Mei, Shiyue, et al.. (2018). Gene mutation analysis and prenatal diagnosis in two families with isovaleric acidemia. Zhonghua weichan yixue zazhi. 21(1). 31–35. 3 indexed citations
12.
Zhang, Jinghua, et al.. (2018). Genetic association between CD86 polymorphisms and the risk of sepsis in a Chinese Han population. Human Immunology. 79(11). 817–820. 3 indexed citations
13.
Zhao, Shuangtao, Nan Bai, Jianlin Cui, Rong Xiang, & Na Li. (2016). Prediction of survival of diffuse large B‐cell lymphoma patients via the expression of three inflammatory genes. Cancer Medicine. 5(8). 1950–1961. 10 indexed citations
14.
Zhang, Yan, Zhujun Zhang, Nan Bai, et al.. (2014). VDR Status Arbitrates the Prometastatic Effects of Tumor-Associated Macrophages. Molecular Cancer Research. 12(8). 1181–1191. 45 indexed citations
15.
Shen, Long, Kunhua Qin, Dekun Wang, et al.. (2014). Overexpression of Oct4 suppresses the metastatic potential of breast cancer cells via Rnd1 downregulation. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1842(11). 2087–2095. 24 indexed citations
16.
Bai, Nan, Chunyan Zhang, Ning Liang, et al.. (2013). Yes-associated protein (YAP) increases chemosensitivity of hepatocellular carcinoma cells by modulation of p53. Cancer Biology & Therapy. 14(6). 511–520. 55 indexed citations
17.
Li, Xiaoqiao, Yan Ma, Dan Li, et al.. (2012). Arsenic impairs embryo development via down-regulating Dvr1 expression in zebrafish. Toxicology Letters. 212(2). 161–168. 35 indexed citations
18.
Zhang, Chunyan, et al.. (2012). TLR2 signaling subpathways regulate TLR9 signaling for the effective induction of IL-12 upon stimulation by heat-killed Brucella abortus. Cellular and Molecular Immunology. 9(4). 324–333. 15 indexed citations
19.
Zhang, Chunyan, Nan Bai, Antao Chang, et al.. (2012). ATF4 is directly recruited by TLR4 signaling and positively regulates TLR4-trigged cytokine production in human monocytes. Cellular and Molecular Immunology. 10(1). 84–94. 85 indexed citations
20.
Bai, Nan, et al.. (1990). Lethal congenital malformations—role in perinatal deaths. The Indian Journal of Pediatrics. 57(4). 581–584. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026